Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Buchczyk, D. P.
Right arrow Articles by Sies, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buchczyk, D. P.
Right arrow Articles by Sies, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 22, No. 6, 879-883, June 2001
© 2001 Oxford University Press


MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

High efficiency of 5-aminolevulinate-photodynamic treatment using UVA irradiation

Darius P. Buchczyk, Lars-Oliver Klotz, Kerstin Lang1,, Clemens Fritsch1, and Helmut Sies2,

1 Institut für Physiologische Chemie I and Hautklinik der Universität, Heinrich-Heine-Universität Düsseldorf, Postfach 101007, D-40001 Düsseldorf, Germany
2 D.P.Buchczyk and L.-O.Klotz contributed equally to this work

Photodynamic therapy (PDT) is being used clinically for the treatment of skin cancers. One concept of delivering the employed photosensitizer directly to target cells is to stimulate cellular synthesis of sensitizers such as porphyrins. ALA (5-aminolevulinate) is applied as a precursor of porphyrins which then serve as endogenous photosensitizers. Upon irradiation, reactive oxygen species, predominantly singlet oxygen, are generated, leading to cell death. ALA–PDT using red light (550–750 nm) is known to lead to the activation of stress kinases, such as c-Jun-N-terminal kinase and p38. These kinases are also activated by UVA (320–400 nm), whose biological effects are mediated in part by singlet oxygen. In the present study, the efficiency of a combination of both treatment strategies, ALA–PDT and UVA, in cytotoxicity and activation of stress kinases was investigated taking human skin fibroblasts as a model. Compared with the commonly used ALA–PDT with red light (LD50 = 13.5 J/cm2), UVA–ALA–PDT was 40-fold more potent in killing cultured human skin fibroblasts (LD50 = 0.35 J/cm2) and still 10-fold more potent than ALA–PDT with green light (LD50 = 4.5 J/cm2). Its toxicity relied on the formation of singlet oxygen, as was shown employing modulators of singlet oxygen lifetime. In line with these data, strong activation of the stress kinase p38 was obtained in ALA-pretreated cells irradiated with UVA at doses two orders of magnitude lower than necessary for a comparable activation of p38 by UVA in control cells. Taken together, these data suggest UVA–ALA–PDT as a potentially interesting new approach in the photodynamic treatment of skin diseases.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
G. T. Wondrak, M. J. Roberts, M. K. Jacobson, and E. L. Jacobson
3-Hydroxypyridine Chromophores Are Endogenous Sensitizers of Photooxidative Stress in Human Skin Cells
J. Biol. Chem., July 16, 2004; 279(29): 30009 - 30020.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Tong, G. Singh, and A. J. Rainbow
Sustained Activation of the Extracellular Signal-regulated Kinase Pathway Protects Cells from Photofrin-mediated Photodynamic Therapy
Cancer Res., October 1, 2002; 62(19): 5528 - 5535.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.